Riskpilot← Back to searchSign inGet full accessSTANDARD BIO AS
ASActiveOrg 996515427Televegen 2, 3802 Bø I TelemarkResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20119 employeeswww.standard.bio
Revenue 2024
NOK 20,4M
-19% vs 2023
EBITDA margin
-27.7%
-23906% vs 2023
Equity ratio
47.6%
Financial strength
Net profit 2024
NOK -16,8M
-548% vs 2023
| Revenue | NOK 20,4M | -19% |
| EBITDA | NOK -5,7M | -23906% |
| Net profit | NOK -16,8M | -548% |
| Total assets | NOK 41,1M | +5% |
| Equity | NOK 19,6M | -2% |
| Employees | 9 | — |
Legal name
STANDARD BIO AS
Org number
996515427
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
3. februar 2011
Share capital
NOK 479 721
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Virke innenfor verdiøkning av biomasse, samt bio raffinering, og det som er forbundet med dette. Selskapets formål er også å virke innenfor kjøp, salg, utleie og drift av anlegg hvor løsningene inngår, samt investeringer relatert til dette.
Address
Televegen 2, 3802 Bø I Telemark
Email
contact@standard.bio
Website
www.standard.bio
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 0 | 0 | 823 | 591 | 2 100 | 2 735 | 2 564 | 3 030 | 3 875 | 6 776 | 8 012 | 25 114 | 20 435 |
| Staff expenses | −0 | −0 | −0 | −827 | −1 185 | −4 654 | −4 596 | −5 496 | −6 732 | −6 251 | −4 556 | −5 517 | −5 875 | −6 472 |
| EBITDA | 1 | −21 | −24 | −1 698 | −4 284 | −7 519 | −5 713 | −8 316 | −8 901 | −8 697 | −7 125 | −5 514 | 24 | −5 662 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −9 | −74 | −494 | −1 606 | −928 | −1 129 | −1 067 | −1 051 | −918 | −905 |
| EBIT | 1 | −21 | −24 | −1 698 | −4 293 | −7 594 | −6 207 | −9 922 | −9 829 | −9 826 | −8 192 | −6 565 | −894 | −6 567 |
| Net financials | 0 | 0 | 0 | 0 | −58 | 107 | −532 | −499 | −818 | −1 229 | −1 061 | −862 | −1 700 | −10 233 |
| Profit before tax | 1 | −21 | −24 | −1 698 | −4 351 | −7 487 | −6 740 | −10 421 | −10 646 | −11 055 | −9 253 | −7 427 | −2 594 | −16 799 |
| Tax | −2 | −6 | −6 | 14 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 3 | −15 | −18 | −1 712 | −4 351 | −7 487 | −6 740 | −10 421 | −10 646 | −11 055 | −9 253 | −7 427 | −2 594 | −16 799 |
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 109 | 104 | 71 | 1 478 | 7 299 | 8 626 | 16 838 | 18 100 | 17 349 | 12 830 | 37 924 | 25 171 | 39 161 | 41 102 |
| Equity | 103 | 88 | 70 | 358 | 5 797 | 1 324 | 9 199 | 8 938 | −1 709 | −12 764 | −317 | 2 256 | 20 072 | 19 574 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 476 | 0 | 5 744 | 7 683 | 8 643 | 7 662 | 6 685 | 5 731 | 4 994 |
| Short-term debt | 5 | 16 | 1 | 1 120 | 1 502 | 6 825 | 7 638 | 3 418 | 11 374 | 16 951 | 30 579 | 16 230 | 13 358 | 16 533 |
| Total debt | 5 | 16 | 1 | 1 120 | 1 502 | 7 301 | 7 638 | 9 162 | 19 057 | 25 593 | 38 241 | 22 915 | 19 089 | 21 528 |
EBITDA margin
-27.7%
This company
15.8%
Market median
-275% vs market
20112024
Equity ratio
47.6%
This company
38.2%
Market median
+25% vs market
20112024
Return on equity
-85.8%
This company
18.4%
Market median
-566% vs market
20112024
Net profit margin
-82.2%
This company
8.1%
Market median
-1115% vs market
20112024
Asset turnover
0.50×
This company
1.12×
Market median
-55% vs market
20112024
Debt / equity
1.10×
This company
0.62×
Market median
-77% vs market
20112024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2010-11-23 – 2011-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 23.9% | 23.9% | 2022 | |
Commercor As | Company | 11.9% | 11.9% | 2022 |
Summen Venture As | Company | 8.8% | 8.8% | 2022 |
| Individual | 7.2% | 7.2% | 2022 | |
Baggins Venture As | Company | 7.2% | 7.2% | 2022 |
Clawback As | Company | 6.5% | 6.5% | 2022 |
Capturebank Holding As | Company | 3.6% | 3.6% | 2022 |
Marchfirst Norway As | Company | 3.2% | 3.2% | 2022 |
Skaltor As | Company | 3.1% | 3.1% | 2022 |
| Individual | 3.0% | 3.0% | 2022 | |
Valtor As | Company | 2.4% | 2.4% | 2022 |
Famara Holding As | Company | 1.9% | 1.9% | 2022 |
Chrisnic Capital As | Company | 1.6% | 1.6% | 2022 |
Krakr As | Company | 1.5% | 1.5% | 2022 |
Huitfeldt-Kaas As | Company | 1.5% | 1.5% | 2022 |
| Individual | 1.5% | 1.5% | 2022 | |
| Individual | 1.2% | 1.2% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Baggins As
STANDARD BIO AS Board members of STANDARD BIO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Morten Erik Iversen | Board of Directors | 0 companies |
| Henrik Johan Wulff | Board of Directors | 0 companies |
| Petter Mannsverk Andresen | Board of Directors | 0 companies |
| Ove Lerdahl | Board of Directors | 0 companies |
| Torkel Dyrbæk Engeness | Board of Directors | 0 companies |
| Kjell Egil Digernes Sommerseth | Board of Directors | 0 companies |
| Tom-Even Mortensen | Chairman | 0 companies |